Organ-specific therapy in critical illness: Interfacing molecular mechanisms with physiological interventions

Journal of Critical Care

Volumn 11, Issue 2, 1996, Pages 95-107

  Pinsky, Michael R ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; ENDOTOXIN; IBUPROFEN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PROSTAGLANDIN E; STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; CHEMOPROPHYLAXIS; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; REVIEW; SEPSIS;

EID: 0030018073     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(96)90024-6     Document Type: Review

References (75)

1. Abraham E, Wunderink R, Silverman HJ, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. JAMA 273:934-941, 1995
2. Abreo K, Moorthy V, Osborne M: Changing patterns and outcome of acute renal failure requiring hemodialysis. Arch Int Med 146:1338-1341, 1986
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
4. Askanazi J, Carpentier Y, Elwyn D: Influence of total parenteral nutrition on fuel utilization in injury and sepsis. Ann Surg 191:40-46, 1980
5. Beutler B, Milsark IW, Cerami A: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871, 1985
6. Beutler B, Tkacenko V, Milsark I: Effect of gamma interferon on cachectin expression by mononuclear phagocytes. J Exp Med 164:1791-17796, 1986
7. Blanch L, Fernandez R, Valle J, et al: Effect of two tidal volumes on oxygenation and respiratory system mechanics during the early stage of adult respiratory distress syndrome. J Crit Care 9:151-158, 1994
8. Bone RC, Fisher CJ, Clemmer TP: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653-659, 1987
9. Breslow MJ, Miller CF, Parker SD: Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 252:H291-298, 1988
10. 2 attenuation of sheep lung responses to endotoxin. J Appl Physiol 64:2568-2574, 1988
11. Butkus DE: Persistent high mortality in acute renal failure. Arch Intern Med 143:209-212, 1983
12. 2 acts at two distinct pathways of T lymphocyte activation: Inhibition of interleukin 2 production and down regulation of transferrin receptor expression. J Immunol 135:1172-1179, 1985
13. Cybulsky MI, Colditz IG, Movat HZ: The role of interleukin-1 in neutrophil leukocyte migration induced by endotoxin. Am J Pathol 124:367-372, 1986
14. Deitch EA, Winterton J, Bey R: The gut as the portal of entry for bacteremia. Ann Surg 205:681-692, 1987
15. Deitch EA, Winterton J, Bey R: The gut as the portal for bacteremia. Ann Surg 205:681-692, 1987
16. Donowitz LG, Wenzel RP, Hoyt JW: High risk of hospital acquired infection in the ICU patient. Crit Care Med 10:335-337, 1982
17. Dreyfuss D, Bassett G, Soler P, Saumon G: Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 132:880-884, 1985
18. Fink MP, Morrissey PE, Stein KL: Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxic rabbits. Circ Shock 26:41-57, 1988
19. Fisher CJ Jr, Dhainaut JF, Opal SM, et al: Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trail. JAMA 271:1836-1843, 1994
20. Fry D, Pearlstein L, Fulton R: Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115:136-140, 1980
21. Gattinoni L, Persenti A, Avalli L, et al: Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136:730-6, 1987
22. Gnidec AC, Sibbald WJ, Cheung H, Metz CA: Ibuprofen reduces the progression of permeability edema in an animal model of hyperdynamic sepsis. J Appl Physiol 65:1024-1032, 1988
23. Greenman RL, Schein RMH, Martin MA: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097-1102, 1991
24. Grootendorst AF, Van Bommel EF, Van Leengoed LA: High volume hemofiltration improves hemodynamics and survival in pigs exposed to gut ischemia and reperfusion. Shock 2:72-78, 1994
25. Grootendorst AF, Van Bommel EF, Van Leengoed LA: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8:161-169, 1993
26. Gutierrez G, Palizas F, Doglio G: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339:195-199, 1992
27. Hack CE, DeGroot ER, Felt-Bersma RJF, et al: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710, 1989
28. Hickling KG, Walsh J, Henderson S: Low mortality rate in the adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 22:1568-1578, 1994
29. Hinchaw LB, Beller BK, Chang ACK: Effect of prior administration of steroids upon recovery from lethal sepsis. Surg Gynecol Obstet 163:335-344, 1986
30. Imai Y, Kawano T, Miyasaka K, et al: Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 150:1550-1554, 1994
31. Jacobs ER, Soulsby ME, Bone RD: Ibuprofen in canine endotoxic shock. J Clin Invest 70:536-541, 1982
32. Kaplan AA, Longnecker RE, Folkert VW: Continuous arterivenous hemofiltration: A report on six months' experience. Ann Intern Med 100:358-367, 1984
33. Kawakami M, Cerami A: Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 154:631-639, 1981
34. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: Prognosis in acute organ-system failure. Ann Surg 202:685-693, 1985
35. Kolobow T, Moretti MP, Fumagalli R: Severe Impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 135:312-315, 1985
36. Ledingham IMcA, Allcock SR, Eastaway AT: Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1:785-790, 1988
37. Matuschak GM, Klein CA, Tredway TL, et al: TNF-α and cyclooxygenase metabolites do not modulate C. Albicans septic shock with disseminated candidiasis. J Appl Physiol 74:2432-2442, 1993
38. Matuschak GM, Mattingly ME, Tredway TL, Lechner AJ: Liver-lung interactions during E coli endotoxemia. Am J Respir Crit Care Med 149:41-49, 1994
39. Matuschak GM, Rinaldo JE: Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest 94:400-406, 1988
40. Matuschak GM, Rinaldo JE, Pinsky MR, et al: Effect of end-stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J Crit Care 2:162-173, 1987
41. Matuschak GM, Shaw BW Jr: Adult respiratory distress syndrome associated with acute liver allograph rejection: Resolution following hepatic retransplantation. Crit Care Med 15:878-881, 1987
42. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blinded, placebo-controlled trial. Ann Intern Med 121:1-5, 1994
43. Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with the acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 273:293-306, 1995
44. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Resp Dis 132:485-489, 1985
45. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295-305, 1994
46. Movat HZ, Cybulsky MI, Colditz IG, et al: Acute inflammation in Gram-negative infection: Endotoxin, interleukin-1, tumor necrosis factor, and neutrophils. Fed Proc 46:97-104, 1987
47. Munchie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988
48. Ossenkoppele GJ, van der Meulen J, Bronsveld W, Thijs LG: Continuous arteriovenous hemofiltration as an adjuctive therapy for septic shock. Crit Care Med 13:102-104, 1985
49. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxation factor. Nature 327:524-526, 1987
50. Parsons PE, Gillespie MK, Moore EE, et al: Neutrophil response to endotoxin in the adult respiratory distress syndrome: Role of CD14. Am J Respir Cell Mol Biol 13:152-160, 1995
51. Pinsky MR: Cardiovascular effects of ventilator support and withdrawal. Anesth Analg 79:567-576, 1994
52. Pinsky MR, Matuschak GM: Multiple systems organ failure: Failure of host defense homeostasis. Crit Care Clinics 5:199-220, 1989
53. Pinsky MR, Matuschak GM: Multiple systems organ failure: A unifying hypothesis. J Crit Care 5:108-114, 1990
54. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock: Relation to multiple systems organ failure and mortality. Chest 103:565-575, 1993
55. Pugin J, Auckthaler R, Lew DP, Suter PM: Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA 265:2704-2710, 1991
56. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic Inflammatory Response Syndrome (SIRS): A prospective study. JAMA 273:117-123, 1995
57. Reidy JJ, Ramsay G: Clinical trials of selective decontamination of the digestive tract: Review. Crit Care Med 18:1449-1456, 1990
58. Rosenbloom A, Pinsky MR, Bryant JL, et al: Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS: Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 274:58-65, 1995
59. Silverman HJ, Slotman G, Bone RC, et al: Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Chest 98:405-410, 1990
60. Smith SD, Jackson RJ, Hannakan CJ: Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation 55:1306-1309, 1993
61. Sprung CL, Caralis PV, Marcial EH: The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137-1143, 1984
62. Stoner HB: Metabolism after trauma and in sepsis. Circ Shock 19:75-87, 1986
63. Stotman GJ, Burchard KW, Williams JJ, D'Anezzo A, Yellin SA: Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery 99:744-751, 1986
64. Tetteroo GW, Wagenvoort JH, Mulder PG, et al: Decreased mortality rate and length of stay in surgical intensive care patients with successful decontamination of the gut. Crit Care Med 21:1692-1698, 1993
65. Tracy KJ, Beutler B, Lowery SF: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986
66. Valenza F, Ribeiro SP, Slutsky AS: High volume low pressure mechanical ventilation up-regulates IL-1β production in an ex vivo lung model. Am J Respir Crit Care Med 151:A552, 1995 (abstr)
67. Vincent J-L, Tielemans C: Continuous hemofiltration in severe sepsis: Is is beneficial? J Crit Care 10:27-32, 1995
68. Waage A: Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol 45:348-355, 1987
69. Waage A, Brandtzaeg P, Halsteusen A, et al: The complex pattern of cytokines in the serum of patients with meningococcal septic shock. J Exp Med 169:333-338, 1989
70. Waage A, Halstensen A, Espevik T: Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987
71. Weksler BB, Goldstein IM: Prostaglandins: Interactions with platelets and polymorphonuclear leukocytes in hemostasis and inflammation. Am J Med 68:419-428, 1980
72. Wright SD, Ramos RA, Tobias PS: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433, 1990
73. Zapol WM, Snider MT, Hill JD: Extracorporeal membrane oxygenation in severe acute respiratory failure: A randomized prospective study. JAMA 242:2193-2196, 1979
74. Ziegler EL, HA-1A Sepsis Study Group: Treatment of gram negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429-436, 1991
75. Ziegler EJ, McCutchan JA, Fierer J: Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant E coli. N Engl J Med 307:1225-1230, 1982